Acronym:
DYNAMIC
ACTRN/NCT /ethics:
ACTRN12615000381583
Scientific title:
Circulating tumour DNA (ctDNA) analysis informing adjuvant chemotherapy in Stage II Colon Cancer
Summary of trial and patient characteristics
| Cancer Type | Bowel and colon | ||
|---|---|---|---|
| Trial Type | Treatment | ||
| Phase | All phases | Tumour Stream | Colon, Rectum |
| Age Range | 18 years and older | Cancer Stage | Locally Recurrent or Locally Advanced |
| Sex | Both | Anticipated Start Date | 2015-05-01 |
| Molecular Target | Anticipated End Date | 2020-01-01 | |
| Cancer Type | Bowel and colon |
|---|---|
| Trial Type | Treatment |
| Phase | All phases |
| Age Range | 18 years and older |
| Sex | Both |
| Molecular Target | |
| Tumour Stream | Colon, Rectum |
| Cancer Stage | Locally Recurrent or Locally Advanced |
| Anticipated Start Date | 2015-05-01 |
| Anticipated End Date | 2020-01-01 |
Trial Summary
This study will determine the effect of the use of circulating tumour DNA (ctDNA) to guide adjuvant chemotherapy on recurrence-free survival in stage II colon or rectal cancer patients
Lay Summary
Circulating tumour DNA (ctDNA) analysis informing adjuvant chemotherapy in Stage II Colon Cancer
Sponsor / Cooperative group
Walter and Eliza Hall Institute
Participating Hospitals
| Hospital | Clinical Trial Coordinator | Phone | Principal Investigator | Recruitment Status | |
|---|---|---|---|---|---|
| Flinders Medical Centre | Alex Scott-Hoy | alex.scott-hoy@sa.gov.au | 08 8204 4830 | Professor Chris Karapetis | Completed |